The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX+/- cetuximab: A PETACC8 translational study.
 
Jean-François Emile
Honoraria - Merck Serono; Roche
Consulting or Advisory Role - Merck Serono; Roche
 
Karine Le Malicot
No Relationships to Disclose
 
Josep Tabernero
No Relationships to Disclose
 
Enrico Mini
No Relationships to Disclose
 
Gunnar Folprecht
Honoraria - Bayer; Lilly/ImClone; Merck KGaA
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Roche/Genentech
Research Funding - Merck KGaA
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Catherine Julie
No Relationships to Disclose
 
Marc Antoine Allard
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Come Lepage
No Relationships to Disclose
 
Pierre Laurent-Puig
No Relationships to Disclose
 
Julien Taïeb
Honoraria - Merck Serono
Consulting or Advisory Role - Merck Serono